TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Kestra Medical Technologies Ltd. ( (KMTS) ).
On December 4, 2025, Kestra Medical Technologies, Ltd. successfully closed an underwritten public offering of 6,900,000 common shares, raising approximately $148.4 million. The proceeds are intended to support sales, marketing, commercialization, research and development, clinical studies, and general corporate purposes.
The most recent analyst rating on (KMTS) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on Kestra Medical Technologies Ltd. stock, see the KMTS Stock Forecast page.
Spark’s Take on KMTS Stock
According to Spark, TipRanks’ AI Analyst, KMTS is a Neutral.
Kestra Medical Technologies Ltd. shows strong revenue growth and strategic achievements, but ongoing profitability challenges and bearish technical indicators weigh heavily on the stock’s outlook. The negative P/E ratio and lack of dividend yield further contribute to a cautious valuation.
To see Spark’s full report on KMTS stock, click here.
More about Kestra Medical Technologies Ltd.
Average Trading Volume: 310,043
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.18B
For detailed information about KMTS stock, go to TipRanks’ Stock Analysis page.